Back to Results

Regenerative Medical Technology Group Inc (RMTG)

Regenerative Medical Technology Group Inc. is a common stock listing on OTC Markets for a company active in regenerative medicine. Through its operations in the United States and abroad, the company supplies products, equipment, solutions, services, and training related to stem cell therapy use. Its business also includes patient treatment, seminars, and the resale of kits and related materials. The company describes recurring use of its process through its kits and solutions. Founded in 1999 and based in Boca Raton, Florida, the business changed its name from Meso Numismatics, Inc. in May 2024.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-RMTG
$0.068
-38.6% Downside
Overvalued
—
—
—
Fair
—
—
—
0.0%
August 14, 2026
-0.2x
0.0x
0.2x
1.445 M
20.964 M
93.4%
95.9%
-44.5
—
19.9%
Valuation • Fair Value

Regenerative Medical Technology Group Inc (OTC-RMTG) Fair Value by Valuation Model

Compare the primary fair value estimate for Regenerative Medical Technology Group Inc (OTC-RMTG) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$0.068

Estimated downside of 38.6% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$0.068

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Regenerative Medical Technology Group Inc (OTC-RMTG) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Regenerative Medical Technology Group Inc (OTC-RMTG)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

6.375 M

Current operating scale indicator.

Revenue Forecast

5.738 M

Forward revenue estimate.

EBITDA

-343.892 K

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Regenerative Medical Technology Group Inc (OTC-RMTG) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Regenerative Medical Technology Group Inc (OTC-RMTG)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-8.37

No elevated caution signal from this screen.

Altman Z-Score

-44.5

Lower score that deserves closer risk review.

FCF / Net Income

19.9%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Regenerative Medical Technology Group Inc (OTC-RMTG). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Regenerative Medical Technology Group Inc (OTC-RMTG)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 14, 2026

Days to Earnings

24

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Regenerative Medical Technology Group Inc (OTC-RMTG), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Regenerative Medical Technology Group Inc (OTC-RMTG) Stock Forecast & Technical Outlook

Review Regenerative Medical Technology Group Inc (OTC-RMTG) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Regenerative Medical Technology Group Inc (OTC-RMTG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Regenerative Medical Technology Group Inc (OTC-RMTG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Regenerative Medical Technology Group Inc (OTC-RMTG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Regenerative Medical Technology Group Inc (OTC-RMTG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Regenerative Medical Technology Group Inc (OTC-RMTG) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Regenerative Medical Technology Group Inc (OTC-RMTG)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Regenerative Medical Technology Group Inc (OTC-RMTG) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Regenerative Medical Technology Group Inc (OTC-RMTG) Stock FAQ

Quick answers about Regenerative Medical Technology Group Inc (OTC-RMTG) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$0.068
Estimated downside 38.6%
Valuation Rating
Overvalued
Estimated downside of 38.6%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Fair
Current financial-health read

The current fair value estimate for Regenerative Medical Technology Group Inc (OTC-RMTG) is $0.068. This implies an estimated downside of 38.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 38.6% versus the current market price.

An analyst price target for Regenerative Medical Technology Group Inc (OTC-RMTG) is not currently available in the latest data file.

The current financial health read for Regenerative Medical Technology Group Inc (OTC-RMTG) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Regenerative Medical Technology Group Inc (OTC-RMTG) is August 14, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Regenerative Medical Technology Group Inc (OTC-RMTG) is -0.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Regenerative Medical Technology Group Inc is 1.445 M.

The current enterprise value listed for Regenerative Medical Technology Group Inc is 20.964 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Regenerative Medical Technology Group Inc is OTC-RMTG, and the stock is listed on OTC Markets.

Regenerative Medical Technology Group Inc (OTC-RMTG) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Regenerative Medical Technology Group Inc is 93.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Regenerative Medical Technology Group Inc is 95.9%. Free float helps investors understand how much of the share base is available for public trading.

Similar Specialty Retail Stocks on OTC Markets View more

Industria de Diseno Textil SA ADR (IDEXY) Industria de Diseno Textil SA ADR (IDEXY)
Fast Retailing Co Ltd ADR (FRCOY) Fast Retailing Co Ltd ADR (FRCOY)
H & M Hennes & Mauritz AB ADR (HNNMY) H & M Hennes & Mauritz AB ADR (HNNMY)
Chow Tai Fook Jewellery Group (CJEWY) Chow Tai Fook Jewellery Group (CJEWY)
Chow Tai Fook Jewellery Group Ltd (CJEWF) Chow Tai Fook Jewellery Group Ltd (CJEWF)
Aritzia Inc (ATZAF) Aritzia Inc (ATZAF)
Avolta AG DRC (DUFRY) Avolta AG DRC (DUFRY)
ZALANDO SE ADR (ZLNDY) ZALANDO SE ADR (ZLNDY)
Kingfisher PLC ADR (KGFHY) Kingfisher PLC ADR (KGFHY)
JD Sports Fashion PLC (JDSPY) JD Sports Fashion PLC (JDSPY)
USS Co Ltd ADR (USSJY) USS Co Ltd ADR (USSJY)
Jumbo SA ADR (JUMSY) Jumbo SA ADR (JUMSY)
Mr Price Group Ltd (MRPLY) Mr Price Group Ltd (MRPLY)
Dunelm Group PLC ADR (DNLMY) Dunelm Group PLC ADR (DNLMY)
Ceconomy AG ADR (MTTRY) Ceconomy AG ADR (MTTRY)
Zhongsheng Group Holdings Ltd ADR (ZSHGY) Zhongsheng Group Holdings Ltd ADR (ZSHGY)
Halfords Group PLC ADR (HLFDY) Halfords Group PLC ADR (HLFDY)
ASOS plc PK (ASOMY) ASOS plc PK (ASOMY)
Boohoo.Com PLC ADR (BHOOY) Boohoo.Com PLC ADR (BHOOY)
Sa Sa International Holdings Ltd ADR (SAXJY) Sa Sa International Holdings Ltd ADR (SAXJY)
Cxj Group Co Ltd (ECXJ) Cxj Group Co Ltd (ECXJ)
GoldMoney Inc (XAUMF) GoldMoney Inc (XAUMF)
Tile Shop Holdings Inc (TTSH) Tile Shop Holdings Inc (TTSH)
Calloway's Nursery Inc (CLWY) Calloway's Nursery Inc (CLWY)